r2rtf
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
A side-by-side editorial comparison of admiralonco and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.
The oncology ADaM helper is dissolving into admiral core, one deprecation at a time.
admiralonco is the oncology companion to admiral, and it ships response-criteria recipes rather than code: RECIST, iRECIST, IMWG, GCIG and PCWG3 each arrive as a vignette plus an ADaM template. Cadence is one or two releases a year, each adding a criteria vignette. The 1.4.0 release began deprecating most of the package's own exported functions in favour of generic admiral equivalents.
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
admiralonco is the oncology companion to admiral, and it ships response-criteria recipes rather than code: RECIST, iRECIST, IMWG, GCIG and PCWG3 each arrive as a vignette plus an ADaM template. Cadence is one or two releases a year, each adding a criteria vignette. The 1.4.0 release began deprecating most of the package's own exported functions in favour of generic admiral equivalents.
The package is converging on a documentation-and-templates model: reusable derivation logic moves upstream into admiral, and admiralonco keeps only the oncology-specific know-how. Every release since 1.0.0 has added a criteria vignette rather than new exported functions, and 1.4.1 extends that by making the template set browsable from the Get Started menu. The surface users program against is shrinking while the guidance they read is growing.
Expect the deprecation cycle started in 1.4.0 to advance through its warning and error phases across the next one or two releases, with new work arriving as another response-criteria vignette rather than new functions.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either admiralonco or pharmaverseadam.
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul took mocking back from webmockr and made it a property of the client itself
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
See all admiralonco alternatives → · See all pharmaverseadam alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
Both compete on the same themes — adam, pharmaverse — within Analytics. admiralonco and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. admiralonco and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top admiralonco alternatives in Analytics are ranked by recent ship velocity. Browse the "admiralonco alternatives" section above for the current picks, or visit /alternatives/admiralonco for the full list with editorial commentary on each.
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.